Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Standard BioTools Inc. has announced an agreement to sell its microfluidics business to Archimed. The deal is expected to close in approximately 30 days, during which time the microfluidics business will continue to operate as part of Standard BioTools.
Standard BioTools agreed to sell its Microfluidics business to healthcare-focused investor ARCHIMED. Closing is targeted in about 30 days, subject to customary closing conditions, with Microfluidics operations remaining at Standard BioTools until the deal closes.